小鵬汽車(09868.HK)9月智能車交付量按年增近2倍 創單月交付新高
小鵬汽車(09868.HK)公佈,公司今年9月交付10,412輛智能車,創單月交付最高記錄,按年增長近2倍,按月增長44%。第三季度交付量25,666輛,刷新季度交付最高記錄,按年增近2倍,按季增長48%。
9月交付的包括7,512輛小鵬智慧轎跑P7,2,656輛緊湊型智慧SUV G3及G3i,以及244輛於9月15日正式上市的百變智能家轎P5。
今年首九個月,公司累計交付量56,404臺,按年增長3.01倍,小鵬P7於9月交付量繼續錄得自上市以來創紀錄的增長,今年首九個月累計交付量39,227輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.